Pruritus
Itch poses ‘major challenge’ in aging adults, but must be addressed
ORLANDO — Itching in older patients should not be dismissed as simply dry skin, but rather approached as a complex problem involving numerous causes, according to a speaker at the American Academy of Dermatology Annual Meeting.
Dupilumab improves lichenification in atopic dermatitis across age, racial groups
Dupilumab rapidly treated and maintained improvements in lichenification, a type of skin thickening from repetitive scratching, among patients of varying ages and races with atopic dermatitis, according to a study.
Q&A: ‘A lot of opportunity’ exists to educate patients on hemodialysis about cannabis use
Patients with kidney disease may be using cannabis recreationally or to treat symptoms without the knowledge of their health care team, according to results of a small survey of patients from a hemodialysis clinic in Canada.
Patients with chronic prurigo commonly experience psychological comorbidities
Patients with chronic prurigo experience high levels of perceived stress, stigmatization and body dysmorphia which are driven by both demographic and disease factors, according to a study.
Allergy, immunology mourns the loss of Marcus Maurer, MD
Allergy and immunology lost a pioneer last summer with the death of Marcus Maurer, MD, executive director of the Institute of Allergology at Charité University Medicine, Berlin.
Topical gel shows promise in treating cutaneous events from EGFR inhibitor cancer therapy
A novel topical gel, HT-001, has shown potential as a treatment for cutaneous side effects from epidermal growth factor receptor inhibitor cancer therapy, according to a Hoth Therapeutics press release detailing phase 2a interim data.
Long-term follow-up in anogenital lichen sclerosus needed to prevent morbidities
Anogenital lichen sclerosus can lead to permanent anatomical changes and sexual discomfort in women, highlighting a need for long-term follow-up and high treatment adherence, the latter of which is lacking, according to a study.
FDA approves Opdivo as subcutaneous injection
The FDA has approved nivolumab and hyaluronidase-nvhy for subcutaneous injection in adults with solid tumors in which nivolumab is indicated, according to a press release.
Tapinarof improves itch, sleep quality for children, adults with atopic dermatitis
BOSTON — Daily tapinarof cream 1% improved weekly itch outcomes and sleep in patients with atopic dermatitis and pruritus, according to an abstract presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Roflumilast may improve atopic dermatitis symptoms, pruritus
BOSTON — Roflumilast cream improved signs and symptoms of atopic dermatitis, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.